DR. JAMES SONG M.D. NPI 1316918626

NPI Details

DR. James Song, M.D. is an urology in Forest Hill, MD with 36 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. James Song, M.D. NPI is 1316918626. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY
Graduation Year:1990

The provider's business location address is:

2007 ROCK SPRING RD
FOREST HILL, MD
ZIP 21050-620
Phone: (410) 879-4879

The NPI 1316918626 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Urinalysis, manual test (HCPCS:81002)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Insertion of implant in urethra within prostate gland using an endoscope, each additional implant (HCPCS:52442)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Biopsy of prostate gland (HCPCS:55700)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Ultrasound scan of prostate through rectum (HCPCS:76873)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies (HCPCS:51729)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Insertion of implant in urethra within prostate gland using an endoscope, 1 implant (HCPCS:52441)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Exam with injections of chemical for destruction of bladder using an endoscope (HCPCS:52287)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Injection of implant material beneath lining of bladder and/or urethra using an endoscope (HCPCS:51715)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Complete laser vaporization of prostate including control of bleeding using an endoscope (HCPCS:52648)
• Prostate resection (HCPCS:NAN14)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 1/27/2006 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.